Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

A CRITICAL point during mammalian pregnancy is the implantation of the blastocyst when the embryo attaches to the wall of the uterus. The autonomously developing preimplantation embryo then becomes dependent on the maternal environment for its continued development. Little is known about the regulation of implantation, except that a complex interaction between peptide and steroid hormones synchronizes the preparation of the uterus for implantation with the development of the embryo. Whether the implantation event is under maternal or embryonic control is also unclear (reviewed in refs 1, 2). We have previously shown that a cytokine, leukaemia inhibitory factor (LIF), is expressed in the uterine endometrial glands specifically on the fourth day of pregnancy3. This burst of expression is under maternal control and always precedes implantation of the blastocyst. Here we report that transient expression of LIF in mice is essential for implantation. Females lacking a functional LIF gene are fertile, but their blastocysts fail to implant and do not develop. The blastocysts, however, are viable and, when transferred to wild-type pseudopregnant recipients, they can implant and develop to term.

[1]  D. Hilton.  LIF: lots of interesting functions. , 1992, Trends in biochemical sciences.

[2]  M. Capecchi,et al.  Altering the genome by homologous recombination. , 1989, Science.

[3]  R. Arceci,et al.  Apparent role of the macrophage growth factor, CSF-1, in placental development , 1987, Nature.

[4]  T. Rose,et al.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Lee,et al.  The genes for leukemia inhibitory factor and interleukin-6 are expressed in mouse blastocysts prior to the onset of hemopoiesis , 1990, Molecular and cellular biology.

[6]  D. Hilton,et al.  Clearance and fate of leukemia‐inhibitory factor (LIF) after injection into mice , 1991, Journal of cellular physiology.

[7]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[8]  Andrew P. McMahon,et al.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain , 1990, Cell.

[9]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[10]  E. Wagner,et al.  Expression of retroviral vectors in transgenic mice obtained by embryo infection. , 1987, The EMBO journal.

[11]  S. Nishikawa,et al.  Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture , 1991, Nature.

[12]  J. Miller.  Myoblast diversity in skeletal myogenesis: How much and to what end? , 1992, Cell.

[13]  A. Kelso,et al.  Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). , 1987, The EMBO journal.

[14]  J. Bazan.  Neuropoietic cytokines in the hematopoietic fold , 1991, Neuron.

[15]  T. Willson,et al.  Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. , 1990, The Journal of biological chemistry.

[16]  R. Arceci,et al.  Role of colony stimulating factor‐1 (CSF‐1) and other lympho‐hematopoietic growth factors in mouse pre‐implantation development , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[18]  David J. Anderson,et al.  CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130 , 1992, Cell.

[19]  C. Stewart,et al.  Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Rossant,et al.  Expression of the c-fms proto-oncogene and of the cytokine, CSF-1, during mouse embryogenesis. , 1989, Developmental biology.

[21]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[22]  B. Tartakovsky,et al.  Cytokines modulate preimplantation development and pregnancy. , 1991, Developmental biology.

[23]  R. Jaenisch,et al.  β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.

[24]  J. D. Neill,et al.  The Physiology of reproduction , 1988 .

[25]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[26]  F. Conquet,et al.  Developmental expression of myeloid leukemia inhibitory factor gene in preimplantation blastocysts and in extraembryonic tissue of mouse embryos , 1990, Molecular and cellular biology.

[27]  W. Wiktor-Jedrzejczak,et al.  A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. , 1991, Developmental biology.

[28]  A. Clarke,et al.  Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells , 1989, Cell.